New hair loss cream shows promise in early trial
Disease control
Completed
This phase 2 trial tested a new drug called TDM-105795 for male pattern baldness. 71 men with mild to moderate hair loss applied a solution to their scalp every day for 16 weeks. The study measured hair count and hair width to see if the treatment helped regrow hair.
Phase: PHASE2 • Sponsor: Technoderma Medicines Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC